[
  {
    "ts": null,
    "headline": "Arcus Biosciences: Many Important Oncology Catalysts Coming Up In 2025",
    "summary": "Read here for more on the potential of RCUS's combination therapies for various cancers, with promising Phase 3 trials and impressive overall survival rates in NSCLC.",
    "url": "https://finnhub.io/api/news?id=b30440ea1c28520941e479be92391b606ee486b00486df7f4834b15d22417496",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736895119,
      "headline": "Arcus Biosciences: Many Important Oncology Catalysts Coming Up In 2025",
      "id": 132397136,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/470612294/image_470612294.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "Read here for more on the potential of RCUS's combination therapies for various cancers, with promising Phase 3 trials and impressive overall survival rates in NSCLC.",
      "url": "https://finnhub.io/api/news?id=b30440ea1c28520941e479be92391b606ee486b00486df7f4834b15d22417496"
    }
  }
]